Crohn's Disease (Pediatric) Clinical Trials

A listing of Crohn's Disease (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 180 clinical trials
featured
  • 32 views
  • 11 Jun, 2020
  • 1 location
featured
Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naïve and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria …

tumor necrosis factor
corticosteroids
maintenance treatment
vedolizumab
remission
  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
A Long Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in Crohn's disease (CD).  

  • 67 views
  • 11 Jun, 2020
  • 1 location
featured
The Scarlet Study for Adults with Moderately to Severely Active Crohn’s Disease

Before beginning the study, patients must go through a screening process to see if they meet the study eligibility requirements. The Screening Period will last about 5 weeks and includes tests and assessments performed at the study clinic.Patients who are eligible for this study will be randomly assigned (like the …

  • 0 views
  • 04 Jun, 2021
  • 6 locations
featured
VIVID-1, a clinical research study for adults 18–80 with moderately to severely active Crohn’s disease.

A phase 3 research study of an injectable investigational medicine for adults ages 18 to 80 with moderate to severe Crohn’s disease. Note that study participants may receive the investigational medication, a currently approved Crohn’s medication, or placebo. The study comprises four periods: screening, treatment period 1, treatment period 2, …

inflammatory bowel disease
gastrointestinal diseases
crohn's disease
gastrointestinal disorder
  • 66 views
  • 20 Jul, 2021
  • 74 locations
Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients

Purpose There is no previous contrast enhanced ultrasound (CEUS) study for pediatric Crohn disease patients. There are adult studies which included adolescent patients. More pediatric patients have been diagnosed as Crohn disease due to dietary change in Korea and it would be cost effective and clinically useful if CEUS was …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

abdominal pain
crohn's disease
ileal disease
corticosteroids
endoscopy
  • 397 views
  • 12 Mar, 2021
  • 388 locations
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

abdominal pain
crohn's disease
ileal disease
corticosteroids
endoscopy
  • 865 views
  • 09 Mar, 2021
  • 421 locations
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

The objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06651600 (200 mg for 8 weeks followed by 50 mg for 4 weeks) dosed once daily and PF-06700841 (60 mg for 12 weeks) dosed once daily during an induction period of 12 weeks, followed …

abdominal pain
vedolizumab
tumor necrosis factor
adalimumab
budesonide
  • 1357 views
  • 28 Jun, 2021
  • 299 locations
Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

Crohn's disease (CD), a chronic inflammatory process in intestinal segments leads to tissue damage. More than two thirds of CD patients need intestinal resection. Symptomatic clinical recurrence occurs in 60% by 10 years. The principal factors affecting postoperative recurrence are active smoking, penetrating disease, perianal lesions history, prior intestinal resection, …

bowel resection
tumor necrosis factor
mercaptopurine
thiopurines
crohn's disease
  • 9 views
  • 27 Mar, 2021
  • 17 locations